These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19728885)

  • 21. Temporin-SHa and Its Analogs as Potential Candidates for the Treatment of
    Olleik H; Baydoun E; Perrier J; Hijazi A; Raymond J; Manzoni M; Dupuis L; Pauleau G; Goudard Y; Villéon B; Goin G; Sockeel P; Choudhary MI; Pasquale ED; Nadeem-Ul-Haque M; Ali H; Khan AI; Shaheen F; Maresca M
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614561
    [No Abstract]   [Full Text] [Related]  

  • 22. Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection.
    Zhang L; Wu WK; Gallo RL; Fang EF; Hu W; Ling TK; Shen J; Chan RL; Lu L; Luo XM; Li MX; Chan KM; Yu J; Wong VW; Ng SC; Wong SH; Chan FK; Sung JJ; Chan MT; Cho CH
    J Immunol; 2016 Feb; 196(4):1799-809. PubMed ID: 26800870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective killing of
    Xiong M; Bao Y; Xu X; Wang H; Han Z; Wang Z; Liu Y; Huang S; Song Z; Chen J; Peek RM; Yin L; Chen LF; Cheng J
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12675-12680. PubMed ID: 29133389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori.
    Zaidi SF; Yoshida I; Butt F; Yusuf MA; Usmanghani K; Kadowaki M; Sugiyama T
    Biol Pharm Bull; 2009 Apr; 32(4):631-6. PubMed ID: 19336896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections.
    Leszczynska K; Namiot D; Byfield FJ; Cruz K; Zendzian-Piotrowska M; Fein DE; Savage PB; Diamond S; McCulloch CA; Janmey PA; Bucki R
    J Antimicrob Chemother; 2013 Mar; 68(3):610-8. PubMed ID: 23134677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbohydrate-Dependent and Antimicrobial Peptide Defence Mechanisms Against Helicobacter pylori Infections.
    Padra M; Benktander J; Robinson K; Lindén SK
    Curr Top Microbiol Immunol; 2019; 421():179-207. PubMed ID: 31123890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastric juice-based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection.
    Hsieh MS; Liu CJ; Hsu WH; Li CJ; Tsai PY; Hu HM; Shih HY; Lu CY; Yu FJ; Kuo FC; Wu DC; Kuo CH
    Helicobacter; 2019 Apr; 24(2):e12568. PubMed ID: 30821043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
    Makobongo MO; Einck L; Peek RM; Merrell DS
    PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
    Erah PO; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    J Antimicrob Chemother; 1997 Jan; 39(1):5-12. PubMed ID: 9044021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of Helicobacter pylori eradication treatment on the MUC 1 and Lewis antigens level in human gastric juice: a preliminary study.
    Radziejewska I; Borzym-Kluczyk M; Kisiel DG; Namiot Z; Wosek J; Gindzieński A
    Dig Dis Sci; 2008 Oct; 53(10):2641-5. PubMed ID: 18409003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cathelicidin protects against Helicobacter pylori colonization and the associated gastritis in mice.
    Zhang L; Yu J; Wong CC; Ling TK; Li ZJ; Chan KM; Ren SX; Shen J; Chan RL; Lee CC; Li MS; Cheng AS; To KF; Gallo RL; Sung JJ; Wu WK; Cho CH
    Gene Ther; 2013 Jul; 20(7):751-60. PubMed ID: 23254369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
    Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
    World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of antimicrobial peptides with anti-Helicobacter pylori activity.
    Neshani A; Zare H; Akbari Eidgahi MR; Hooshyar Chichaklu A; Movaqar A; Ghazvini K
    Helicobacter; 2019 Feb; 24(1):e12555. PubMed ID: 30440101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of antimicrobial peptides expressed by host cells upon infection by Helicobacter pylori.
    Gopal R; Jeong E; Seo CH; Park Y
    Protein Pept Lett; 2014; 21(10):1057-64. PubMed ID: 25001211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Grafting MSI-78A onto chitosan microspheres enhances its antimicrobial activity.
    Fonseca DR; Moura A; Leiro V; Silva-Carvalho R; Estevinho BN; Seabra CL; Henriques PC; Lucena M; Teixeira C; Gomes P; Parreira P; Martins MCL
    Acta Biomater; 2022 Jan; 137():186-198. PubMed ID: 34634508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
    Nobata K; Ina K; Ohta M; Kawamura-Sato K; Tsuzuki T; Ando T; Kusugami K
    Dig Liver Dis; 2002 Jul; 34(7):489-97. PubMed ID: 12236482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human gastric mucins differently regulate Helicobacter pylori proliferation, gene expression and interactions with host cells.
    Skoog EC; Sjöling Å; Navabi N; Holgersson J; Lundin SB; Lindén SK
    PLoS One; 2012; 7(5):e36378. PubMed ID: 22563496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Helicobacter pylori potential of artemisinin and its derivatives.
    Goswami S; Bhakuni RS; Chinniah A; Pal A; Kar SK; Das PK
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4594-607. PubMed ID: 22687518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial killing in gastric juice--effect of pH and pepsin on Escherichia coli and Helicobacter pylori.
    Zhu H; Hart CA; Sales D; Roberts NB
    J Med Microbiol; 2006 Sep; 55(Pt 9):1265-1270. PubMed ID: 16914658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.
    Boyanova L; Stancheva I; Spassova Z; Katzarov N; Mitov I; Koumanova R
    J Med Microbiol; 2000 May; 49(5):415-418. PubMed ID: 10798553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.